Metropolis Healthcare Ltd

Metropolis Healt Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Metropolis Healthcare Ltd

₹ 2,020 0.39%
03 Jul 9:10 a.m.
metropolisindia.com BSE: 542650 NSE: METROPOLIS
About

Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South Asia, Africa and the Middle East.

Key Points

Leading Diagnostics company[1] Metropolis Healthcare Ltd is the second largest Diagnostic company in India and the largest player in Western and Southern India.

Website BSE NSE
  • Market Cap ₹ 10,348 Cr.
  • Current Price ₹ 2,020
  • High / Low ₹ 2,080 / 1,296
  • Stock P/E 81.0
  • Book Value ₹ 214
  • Dividend Yield 0.40 %
  • ROCE 15.4 %
  • ROE 12.3 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has reduced debt.

Cons

  • Stock is trading at 9.41 times its book value
  • The company has delivered a poor sales growth of 9.67% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
292 327 303 293 306 280 300 285 283 277 308 291 331
195 224 212 218 231 211 221 215 212 214 234 226 251
Operating Profit 96 102 90 75 75 68 79 70 70 63 75 65 80
OPM % 33% 31% 30% 26% 24% 24% 26% 25% 25% 23% 24% 22% 24%
2 20 6 3 6 3 4 7 1 3 1 2 3
Interest 3 6 3 5 6 8 7 6 6 6 6 5 6
Depreciation 14 13 15 17 18 21 22 23 23 21 22 25 26
Profit before tax 82 103 78 56 56 43 55 48 42 39 48 37 51
Tax % 25% 27% 25% 27% 29% 22% 26% 25% 20% 26% 26% 26% 28%
61 75 58 41 40 34 40 36 33 29 36 27 37
EPS in Rs 12.00 14.65 11.39 8.02 7.81 6.53 7.88 6.99 6.51 5.62 6.92 5.30 7.11
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
388 456 475 545 647 761 856 998 1,228 1,148 1,208
285 339 359 405 467 559 619 708 880 855 925
Operating Profit 104 117 116 140 181 203 237 290 348 293 283
OPM % 27% 26% 24% 26% 28% 27% 28% 29% 28% 26% 23%
10 7 29 39 6 8 -17 12 34 15 9
Interest 3 2 2 2 4 4 13 12 25 32 23
Depreciation 16 21 17 17 19 20 39 46 63 89 94
Profit before tax 95 101 128 160 164 187 169 244 293 188 175
Tax % 34% 33% 36% 33% 32% 34% 24% 25% 27% 24% 26%
63 68 82 107 112 124 128 183 215 143 128
EPS in Rs 57.34 61.82 80.47 106.52 109.23 23.94 25.15 35.82 41.85 27.90 24.95
Dividend Payout % 2% 0% 100% 49% 0% 55% 32% 22% 19% 29% 0%
Compounded Sales Growth
10 Years: 12%
5 Years: 10%
3 Years: 7%
TTM: 5%
Compounded Profit Growth
10 Years: 9%
5 Years: 2%
3 Years: -11%
TTM: -11%
Stock Price CAGR
10 Years: %
5 Years: 16%
3 Years: -11%
1 Year: 38%
Return on Equity
10 Years: 22%
5 Years: 21%
3 Years: 17%
Last Year: 12%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 10 10 10 10 10 10 10 10 10 10 10
Reserves 292 352 269 314 405 408 513 696 876 978 1,086
20 14 5 1 1 18 67 112 379 266 197
69 87 107 188 110 113 160 181 256 240 262
Total Liabilities 391 462 391 512 526 550 750 1,000 1,521 1,495 1,555
149 153 142 202 207 213 296 343 1,059 1,121 1,177
CWIP 1 0 1 1 0 6 3 0 6 20 0
Investments 132 168 101 142 102 33 14 10 16 15 55
109 141 147 167 216 298 437 647 440 340 323
Total Assets 391 462 391 512 526 550 750 1,000 1,521 1,495 1,555

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
77 69 91 102 104 90 215 249 253 247 264
-61 -56 96 -86 1 36 -104 63 -736 48 -89
-14 -9 -174 -17 -87 -118 -55 -33 163 -292 -181
Net Cash Flow 2 4 14 -1 18 8 56 279 -321 3 -7

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 47 57 54 54 57 66 55 45 40 39 38
Inventory Days 47 52 46 38 53 55 44 59 68 64 58
Days Payable 75 92 96 97 88 90 152 160 136 136 150
Cash Conversion Cycle 19 17 3 -5 21 30 -54 -56 -29 -33 -53
Working Capital Days 22 32 8 -27 28 42 11 4 14 14 23
ROCE % 28% 34% 46% 43% 43% 40% 36% 29% 17%

Shareholding Pattern

Numbers in percentages

4 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
50.37% 50.33% 49.50% 49.79% 49.79% 49.76% 49.76% 49.75% 49.75% 49.75% 49.74% 49.67%
28.59% 30.72% 30.06% 21.91% 23.20% 25.57% 23.86% 25.67% 25.66% 24.29% 21.66% 18.90%
14.59% 12.26% 11.35% 16.20% 14.50% 12.38% 13.30% 13.64% 14.89% 16.86% 20.73% 24.86%
6.45% 6.69% 9.09% 12.11% 12.52% 12.30% 13.09% 10.94% 9.69% 9.10% 7.87% 6.57%
No. of Shareholders 33,52743,55264,16879,89586,40490,09091,45284,26989,69286,24979,87868,283

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls